Potential tolerance against bromobenzene-induced acute hepatotoxicity due to prior subchronic exposure
Author:
- 1 October 1991
- journal article
- Published by Springer Nature in Archives of Toxicology
- Vol. 65 (8) , 681-684
Abstract
Groups of adult male Sprague-Dawley rats were treated i.p. with 0, 0.3 and 0.5 mmole bromobenzene (BB)/kg per day in corn oil, 5 days a week for 4 weeks. Thereafter, one half of each of these groups was treated i. p. with a single acute toxic dose of 2.5 mmole BB/kg. Urines were then collected for 24 h and the animals were then sacrificed. The hepatotoxicity induced by an acute dose of BB was significantly reduced due to prior subchronic exposure to BB at 0.5 mmol/kg, but not so at 0.3 mmol/kg. These data indicate a potential tolerance against acute hepatotoxicity of BB due to prior subchronic exposure. A significant increase in the urinary excretion of thioethers or mercapturic acids of BB combined with a significant increase in the urinary level ofp-bromocatechol due to prior subchronic treatment with 0.5 mmol BB/kg relative to those due to acute treatment alone was observed. Thus enhanced bromobenzene metabolism could partly explain such potential tolerance against its acute hepatotoxicity. Such protection may also be related to certain cellular events which might occur subsequent to metabolic activation of BB.Keywords
This publication has 11 references indexed in Scilit:
- Dose‐dependent metabolic excretion of bromobenzene and its possible relationship to hepatotoxicity in ratsJournal of Toxicology and Environmental Health, 1984
- Increased activity of certain hepatic drug-metabolizing enzymes due to subchronic exposure to bromobenzeneToxicology Letters, 1983
- Metabolic activation and detoxification of bromobenzene leading to cytotoxicity.The Journal of Pharmacology and Experimental Therapeutics, 1980
- Detection and identification of S-methylcysteine in urine of workers exposed to methyl chlorideInternational Archives of Occupational and Environmental Health, 1980
- Bromobenzene-Induced Liver Necrosis. Protective Role of Glutathione and Evidence for 3,4-Bromobenzene Oxide as the Hepatotoxic MetabolitePharmacology, 1974
- ROLE OF DETOXIFYING ENZYMES IN BROMOBENZENE-INDUCED LIVER NECROSISThe Journal of Pharmacology and Experimental Therapeutics, 1973
- Centrolobular hepatic necrosis related to covalent binding of metabolites of halogenated aromatic hydrocarbonsExperimental and Molecular Pathology, 1973
- PHARMACOLOGICAL IMPLICATIONS OF MICROSOMAL ENZYME INDUCTIONPharmacological Reviews, 1967
- Serum Glutamic Pyruvic Transaminase in Cardiac and Hepatic Disease.Experimental Biology and Medicine, 1956
- TRANSAMINASE ACTIVITY IN HUMAN BLOODJournal of Clinical Investigation, 1955